FDA Receives New Dietary Ingredient Notification for Cannabis Sativa Essential Oil

Mondays Foods LLC has submitted a New Dietary Ingredient notification to the FDA for Cannabis Sativa L. essential oil. This filing represents another formal attempt by a manufacturer to establish safety data and secure a pathway for hemp-derived ingredients in the dietary supplement market. How the agency responds will signal whether federal regulators are softening their posture toward non-cannabinoid or low-cannabinoid botanical extracts.

Clinical & Patient Impact

Essential oils derived from cannabis often contain rich terpene profiles while remaining virtually free of cannabinoids like THC and CBD. If accepted without objection, this ingredient could offer consumers standardized botanical products with recognized safety dossiers. For clinicians, clearer regulatory oversight of these secondary plant compounds helps establish reliable quality standards and reduce contamination risks for patients seeking non-cannabinoid plant therapies.